Clinical trial
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
NCT00004381 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00004381 |
|---|---|
| Title | Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | Rockefeller University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Glucosephosphate Dehydrogenase Deficiency, Hyperbilirubinemia, Hemolytic Disease of Newborn |
| Intervention type | Drug |
| Interventions | tin mesoporphyrin |
| Start date | Dec 1, 1999 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: